Stocks/Funds/CIK 1757283

Andera Partners

concentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 1757283
Assets
$177M
Holdings
7
Lifetime alpha vs market
-26.91% annual
Average hold time
0.4 yr
median 0.5 yr

Quarterly history

Cum return -12% vs S&P -4% · α -7% lifetimeAUM $177M · peak $177MFlow $21M (+12%)2025-122026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
+2.86%
adds when stocks drop
when a holding falls −10%+
Middle response
Rally response
+0.00%
adds into rallies
when a holding rises +10%+

Top positions · 7

Ticker$ value% portYoYHold time
KMTSKestra Medical Technolog$54M30.4%0.5 yr
EVMNEvommune, Inc.$44M24.7%0.5 yr
MLYSMineralys Therapeutics, $43M24.4%0.5 yr
AGMBAgomAb Therapeutics N.V.$16M9.1%0.3 yr
IVAInventiva S.A.$10M5.7%0.5 yr
ABVXAbivax S.A.$9M4.9%0.5 yr
$2M0.9%0.3 yr

Portfolio composition (YoY)

Industry mix
Biotechnology68.8%$122M
Medical - Instruments & Supplies30.4%$54M
Unknown0.9%$2M
Country
US79.4%
FR10.6%
BE9.1%
Unknown0.9%
Top 5: 94.2% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 3

new+$0M
AGMB AgomAb Therapeutics N.V. Amerinew+$16M
KMTS Kestra Medical Technologies, L+$54M

Top sells this quarter · 0

No sells this quarter

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$177M7-11.58%-4.37%-7.21%+0.02B
2025-12-31$177M5